29 Aprile 2026 Lauciello N, Russo G, Stefano A. Radiomics in preclinical imaging: current trends and future directions. Clinical and Translational Imaging (Published on-line: March 23, 2026) Lorena Bonaldi Pubblicazioni - 2026 Lauciello N, Russo G, Stefano A. Radiomics in preclinical imaging: current trends and future directions. Clinical and Translational Imaging (Published on-line: March 23, 2026).
29 Aprile 2026 Finti A, Marinozzi F, Pasini G, Russo G, Stefano A, Bini F. Digital Pathology-Based Comparison of PyRadiomics and HistomicsTK for Nuclei Classification in Melanoma Whole Slide Images. Int J Biomed Imaging, 2026; 2026: 7419529 Lorena Bonaldi Pubblicazioni - 2026 Finti A, Marinozzi F, Pasini G, Russo G, Stefano A, Bini F. Digital Pathology-Based Comparison of PyRadiomics and HistomicsTK for Nuclei Classification in Melanoma Whole Slide Images. Int J Biomed Imaging, 2026; 2026: 7419529.
28 Aprile 2026 Mumoli L, Magro G, Saraceno A, Bosco D. More than a gut feeling: a case of fatal double positive (anti-Sox1, anti-Hu) encephalitis. Am J Med, 2026; 139 (7): 882-883 Lorena Bonaldi Pubblicazioni - 2026 Mumoli L, Magro G, Saraceno A, Bosco D. More than a gut feeling: a case of fatal double positive (anti-Sox1, anti-Hu) encephalitis. Am J Med, 2026; 139 (7): 882-883.
15 Aprile 2026 Alberghina C, Torrisi F, Valable S, Sarrazin E, Blanchard I, Vela A, Bravatà V, Botta L, Lanzanò L, Scalisi S, Demichelis MP, Sabini MG, Patti IV, Russo G, Cammarata FP, Parenti R. Evaluation of a Boron-Conjugated SRC Inhibitor Combined with Proton and X-Ray Irradiation in U-87 MG and U-87 MG IDH1R132H Glioma Cell Lines. Pharmaceutical, 2026; 19 (3): 392 Lorena Bonaldi Pubblicazioni - 2026 Alberghina C, Torrisi F, Valable S, Sarrazin E, Blanchard I, Vela A, Bravatà V, Botta L, Lanzanò L, Scalisi S, Demichelis MP, Sabini MG, Patti IV, Russo G, Cammarata FP, Parenti R. Evaluation of a Boron-Conjugated SRC Inhibitor Combined with Proton and X-Ray Irradiation in U-87 MG and U-87 MG IDH1R132H Glioma Cell Lines. Pharmaceutical, 2026; 19 (3): 392.
8 Aprile 2026 Gervasoni C, Ceriani C, Lanzotti A, Negri S, Guzzo F, Pirovano F, Galuzzi BG, Annè F, Inguscio A, Lo Dico A, Porro D, Bertoli GR. Salvia pratensis exhibits in vitro anti-cancer effects in triple-negative breast cancer through miR-34a-5p signaling. Front Nutr, 2026; :13: 1786148 Lorena Bonaldi Pubblicazioni - 2026 Gervasoni C, Ceriani C, Lanzotti A, Negri S, Guzzo F, Pirovano F, Galuzzi BG, Annè F, Inguscio A, Lo Dico A, Porro D, Bertoli GR. Salvia pratensis exhibits in vitro anti-cancer effects in triple-negative breast cancer through miR-34a-5p signaling. Front Nutr, 2026; :13: 1786148.
3 Marzo 2026 Bravatà V, Calvaruso M, Pucci G, Carollo PS, Lauciello N, Negri S, Guzzo F, Santoro V, Sarnari F, Bonanomi M, Mallia S, Russo G, Forte GI, Minafra L. Cell and molecular effects induced by Cistus monspeliensis L. and Cistus laurifolius L. phytoextracts in X-ray-irradiated breast cancer cell lines. J Radiat Res Appl Sci, 2026; 19 (1): 102267 Lorena Bonaldi Pubblicazioni - 2026 Bravatà V, Calvaruso M, Pucci G, Carollo PS, Lauciello N, Negri S, Guzzo F, Santoro V, Sarnari F, Bonanomi M, Mallia S, Russo G, Forte GI, Minafra L. Cell and molecular effects induced by Cistus monspeliensis L. and Cistus laurifolius L. phytoextracts in X-ray-irradiated breast cancer cell lines. J Radiat Res Appl Sci, 2026; 19 (1): 102267.
25 Febbraio 2026 Lapi F, Milazzo L, Lin L, Rizzo IC, Galuzzi BG, Damiani C. COBRAxy: constraint-based metabolic modeling in Galaxy. Bioinformatics, 2026; 42 (2); btaf670 Lorena Bonaldi Pubblicazioni - 2026 Lapi F, Milazzo L, Lin L, Rizzo IC, Galuzzi BG, Damiani C. COBRAxy: constraint-based metabolic modeling in Galaxy. Bioinformatics, 2026; 42 (2); btaf670.
25 Febbraio 2026 Colica C, Vecchio I, Aiello E, Abenavoli L, Scarlata GGM, Aiello V. Gut microbiota: origin or panacea for all ills? Gut microbiota and systemic diseases. Microb Pathog, 2026; 212: 108299 Lorena Bonaldi Pubblicazioni - 2026 Colica C, Vecchio I, Aiello E, Abenavoli L, Scarlata GGM, Aiello V. Gut microbiota: origin or panacea for all ills? Gut microbiota and systemic diseases. Microb Pathog, 2026; 212: 108299.
25 Febbraio 2026 Colica C, Vecchio I. Gut microbiota: origin or panacea for all ills? Immune and metabolic diseases, nutrition, and microbiota-based interventions. Microb Pathog, 2026; 212: 108213 Lorena Bonaldi Pubblicazioni - 2026 Colica C, Vecchio I. Gut microbiota: origin or panacea for all ills? Immune and metabolic diseases, nutrition, and microbiota-based interventions. Microb Pathog, 2026; 212: 108213.
20 Febbraio 2026 Martelli C, Bonanomi M, Pellizzer C, Giammona A. Remedia S, Nespoli M,Gaglio D, Capitanio D, Porro D, Ottobrini L, Lo Dico A. miRNA675-5p inhibitor’s dual role as novel therapeutic alternative or sensitizing treatment in resistant glioma models. Molecular Therapy Nucleic Acids, 2026; 37 (1): 102647 Lorena Bonaldi Pubblicazioni - 2026 Martelli C, Bonanomi M, Pellizzer C, Giammona A. Remedia S, Nespoli M,Gaglio D, Capitanio D, Porro D, Ottobrini L, Lo Dico A. miRNA675-5p inhibitor’s dual role as novel therapeutic alternative or sensitizing treatment in resistant glioma models. Molecular Therapy Nucleic Acids, 2026; 37 (1): 102647.
